Literature DB >> 32853981

The domino effect triggered by the tethered ligand of the protease activated receptors.

Xu Han1, Marvin T Nieman2.   

Abstract

Protease activated receptors (PARs) are G-protein coupled receptors (GPCRs) that have a unique activation mechanism. Unlike other GPCRs that can be activated by free ligands, under physiological conditions, PARs are activated by the tethered ligand, which is a part of their N-terminus that is unmasked by proteolysis. It has been 30 years since the first member of the family, PAR1, was identified. In this review, we will discuss this unique tethered ligand mediate receptor activation of PARs in detail: how they interact with the proteases, the complex structural rearrangement of the receptors upon activation, and the termination of the signaling. We also summarize the structural studies of the PARs and how single nucleotide polymorphisms impact the receptor reactivity. Finally, we review the current strategies for inhibiting PAR function with therapeutic targets for anti-thrombosis. The focus of this review is PAR1 and PAR4 as they are the thrombin signal mediators on human platelets and therapeutics targets. We also include the structural studies of PAR2 as it informs the mechanism of action for PARs in general.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32853981      PMCID: PMC7686079          DOI: 10.1016/j.thromres.2020.08.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  147 in total

1.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  Molecular mapping of thrombin-receptor interactions.

Authors:  Y M Ayala; A M Cantwell; T Rose; L A Bush; D Arosio; E Di Cera
Journal:  Proteins       Date:  2001-11-01

3.  Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.

Authors:  Paul A Gurbel; Kevin P Bliden; Susan E Turner; Udaya S Tantry; Martin G Gesheff; Travis P Barr; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01       Impact factor: 8.311

4.  Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.

Authors:  P Ghanouni; Z Gryczynski; J J Steenhuis; T W Lee; D L Farrens; J R Lakowicz; B K Kobilka
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

5.  Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.

Authors:  Samuel Chackalamannil; Yuguang Wang; William J Greenlee; Zhiyong Hu; Yan Xia; Ho-Sam Ahn; George Boykow; Yunsheng Hsieh; Jairam Palamanda; Jacqueline Agans-Fantuzzi; Stan Kurowski; Michael Graziano; Madhu Chintala
Journal:  J Med Chem       Date:  2008-05-01       Impact factor: 7.446

6.  A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.

Authors:  S J Compton; J A Cairns; K J Palmer; B Al-Ani; M D Hollenberg; A F Walls
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

7.  Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1.

Authors:  Louisa Dowal; Derek S Sim; James R Dilks; Price Blair; Sarah Beaudry; Bradley M Denker; Georgios Koukos; Athan Kuliopulos; Robert Flaumenhaft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 8.  G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins.

Authors:  S S Ferguson; L S Barak; J Zhang; M G Caron
Journal:  Can J Physiol Pharmacol       Date:  1996-10       Impact factor: 2.273

9.  Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.

Authors:  Lidija Covic; Meghna Misra; Jehangir Badar; Christopher Singh; Athan Kuliopulos
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

10.  ALIX binds a YPX(3)L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting.

Authors:  Michael R Dores; Buxin Chen; Huilan Lin; Unice J K Soh; May M Paing; William A Montagne; Timo Meerloo; JoAnn Trejo
Journal:  J Cell Biol       Date:  2012-04-30       Impact factor: 10.539

View more
  6 in total

Review 1.  Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives.

Authors:  Shirin Kahremany; Lukas Hofmann; Marco Harari; Arie Gruzman; Guy Cohen
Journal:  Pharmacol Rep       Date:  2021-01-18       Impact factor: 3.024

Review 2.  Protease-activated receptors: An illustrated review.

Authors:  Xu Han; Marvin T Nieman; Bryce A Kerlin
Journal:  Res Pract Thromb Haemost       Date:  2020-12-06

3.  Endothelial Protease Activated Receptor 1 (PAR1) Signalling Is Required for Lymphocyte Transmigration across Brain Microvascular Endothelial Cells.

Authors:  Silvia Dragoni; Anna Papageorgiou; Caroline Araiz; John Greenwood; Patric Turowski
Journal:  Cells       Date:  2020-12-21       Impact factor: 6.600

Review 4.  The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.

Authors:  Barry W Festoff; Chris Dockendorff
Journal:  Biomolecules       Date:  2021-10-21

Review 5.  Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves.

Authors:  Elena Pompili; Valerio De Franchis; Claudia Giampietri; Stefano Leone; Elena De Santis; Francesco Fornai; Lorenzo Fumagalli; Cinzia Fabrizi
Journal:  Biomolecules       Date:  2021-11-10

Review 6.  Diversification of PAR signaling through receptor crosstalk.

Authors:  Irene Lee-Rivera; Edith López; Ana María López-Colomé
Journal:  Cell Mol Biol Lett       Date:  2022-09-10       Impact factor: 8.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.